Breast Biopsy Devices Market Is Expected To Generate A Revenue Of USD 3,930.7 million By 2030

The latest market report published by Credence Research, Inc. “Global Breast Biopsy Devices Market: Growth, Future Prospects, and Competitive Analysis, 2017 – 2030”. The Global Breast Biopsy Devices Market generated revenue of around USD 2,648.9 million in 2022 and is anticipated to grow a CAGR of over 5.80% during the forecast period from 2023 to 2030 to reach around USD 3,930.7 million in 2030.

Breast tumor detection is accomplished using various imaging methods, including ultrasound, mammography, and magnetic resonance imaging. The growing demand for non-radiation biopsies and the increasing demand for minimally invasive procedures, the ultrasound segment is anticipated to grow the fastest. Market growth is estimated to be driven by an increase in breast cancers in women worldwide and cancer awareness screening programs. This industry is also expected to benefit from continuously introducing new product enhancements during the forecast period.

The global breast biopsy devices market is bifurcated into Product, Technique Type, Guidance Technology, End User, and Geography. Based on product, the market is categorized into biopsy needles, biopsy tables, biopsy wires, guidance systems, and others. On the basis of Technique Type, the global market is segmented into Fine Needle Aspiration Biopsy, Core Needle Biopsy, Biopsy Markers, Mri-Guided Core Needle Biopsy, Surgical Biopsy, Wire Localization, and Sentinel Node Biopsy. Based on Guidance Technology, the market is categorized into Fine Ultrasound-Guided, Mammography-Guided Magnetic Resonance, Ct-Guided Biopsy, and Other Image-Guided Breast Biopsy. On the basis of End Users, the global market is segmented into Hospitals, Ambulatory Surgical Centres, Diagnostic Centres, and Others. Based on geography, the market is segmented as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

In 2022, North America dominated the global breast biopsy devices market and accounted for a major market revenue share in terms of value. North America has seen an increase in cancer prevalence in recent years. Cancer is the leading cause of death in this region. The region has adopted various advanced technologies in recent years. In this region, market growth is primarily driven by the adoption of high-tech devices in the healthcare sector, increased healthcare expenditures, the prevalence of breast cancer, and patient awareness about mammograms for detecting it.

Breast Biopsy Devices Market Major Challenges are numerous and complex. One of the most significant challenges is the lack of awareness among healthcare professionals and patients about breast biopsy devices, their benefits, and appropriate usage. Additionally, a shortage of skilled radiologists to perform biopsies has resulted in longer wait times for patients seeking diagnosis or treatment. Another challenge faced by the market is the high cost associated with these devices, which may limit access for many patients who cannot afford them. Furthermore, regulatory hurdles related to obtaining approval for new technologies have also been an obstacle for companies trying to introduce innovations in this space.

Breast biopsy devices market top trends are constantly evolving to meet the ever-changing needs of patients and healthcare professionals. With the surge in demand for early detection and diagnosis of breast cancer, there has been an increasing focus on developing new technologies that offer accurate and minimally invasive biopsy procedures. One of the key trends in this market is the use of vacuum-assisted biopsy (VAB) devices that allow for more tissue sampling with greater accuracy than traditional needle biopsies. Another trend is the integration of imaging techniques such as ultrasound or magnetic resonance imaging (MRI) into biopsy procedures, which enhances diagnostic accuracy by providing real-time images during a biopsy. Additionally, advancements in robotics technology have led to robotic-assisted breast biopsy devices, allowing for greater precision and control during procedures. The Breast Biopsy Devices Market Top Trends also includes developments in software solutions that aid physicians in analyzing tissue samples faster and more accurately, improving patient care outcomes overall.

The regional analysis of the breast biopsy devices market:

  • North America: The North American region is one of the largest markets for breast biopsy devices, driven by factors such as increasing awareness about breast cancer screening, rising incidence of breast cancer, and the presence of well-established healthcare infrastructure. The United States is the largest market in this region, with Canada following suit. The market growth is also attributed to the presence of major players and the availability of advanced diagnostic technologies.
  • Europe: Europe is another significant market for breast biopsy devices, driven by the increasing prevalence of breast cancer and the presence of a well-established healthcare infrastructure. The United Kingdom, Germany, and France are the largest markets in this region. The market growth is also attributed to the increasing adoption of minimally invasive breast biopsy procedures and favorable reimbursement policies.
  • Asia Pacific: The Asia Pacific region is expected to witness the highest growth rate in the breast biopsy devices market, driven by factors such as increasing awareness about breast cancer screening, rising incidence of breast cancer, and the presence of a large patient pool. China and India are the largest markets in this region. The market growth is also attributed to the increasing adoption of advanced diagnostic technologies and the improving healthcare infrastructure.
  • Latin America: Latin America is a growing market for breast biopsy devices, driven by factors such as increasing awareness about breast cancer screening and the presence of a large patient pool. Brazil and Mexico are the largest markets in this region. The market growth is also attributed to the increasing adoption of minimally invasive breast biopsy procedures.
  • Middle East and Africa: The Middle East and Africa region is a growing market for breast biopsy devices, driven by factors such as increasing awareness about breast cancer screening, rising incidence of breast cancer, and the improving healthcare infrastructure. Saudi Arabia and South Africa are the largest markets in this region. The market growth is also attributed to the increasing adoption of advanced diagnostic technologies and the favorable regulatory environment.

Why to Buy This Report-

  • The report provides a qualitative and quantitative analysis of the global breast biopsy devices market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2018-2021, base year- 2022, and forecast period 2023-2030.
  • The report contains information related to the competitive landscape, like how the key players in the market are operating at a global, regional, and country level
  • In-depth analysis of the market segmentation of the global breast biopsy devices based on product, technique type, guidance technology, and end user.
  • The global breast biopsy devices market report also includes analyzing the global, regional, and country level, along with key market trends, significant players analysis, market growth strategies, and key application areas.

Browse Full Report: https://www.credenceresearch.com/report/breast-biopsy-devices-market

Visit: https://www.credenceresearch.com/

Related Report: https://www.credenceresearch.com/report/menstrual-cups-market

Related Report: https://www.credenceresearch.com/report/digital-diagnostics-market

Browse Our Blog: https://www.linkedin.com/pulse/breast-biopsy-devices-market-size-worth-usd-39307-million-singh

Leave a Reply

Your email address will not be published.